temozolomide has been researched along with CACH Syndrome in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The EpiBrainRad study is a prospective cohort study including newly diagnosed high grade gliomas patients treated by radiotherapy and concomitant-adjuvant temozolomide chemotherapy." | 3.81 | EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. ( Benderitter, M; Bernier, MO; Brochet, B; Delattre, JY; Douzane, H; Durand, T; Feuvret, L; Hoang-Xuan, K; Jacob, S; Lebouil, L; Leclercq, D; Lestaevel, P; Milliat, F; Noël, G; Psimaras, D; Rahimian, A; Ricard, D; Tamarat, R; Vayatis, N, 2015) |
| "Following tumor resection, the majority of high-grade glioma (HGG) patients are treated with a combined modality regimen of radiotherapy and temozolomide." | 3.80 | Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study. ( Bosma, I; Buter, J; de Groot, M; Douw, L; Froklage, FE; Heimans, JJ; Klein, M; Lagerwaard, FJ; Oosterbaan, LJ; Postma, TJ; Reijneveld, JC; Sanchez, E; Sizoo, EM; Uitdehaag, BM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pedroso, JL | 1 |
| Munford, V | 1 |
| Bastos, AU | 1 |
| Castro, LP | 1 |
| Marussi, VHR | 1 |
| Silva, GS | 1 |
| Arita, JH | 1 |
| Menck, CFM | 1 |
| Barsottini, OG | 1 |
| Froklage, FE | 1 |
| Oosterbaan, LJ | 1 |
| Sizoo, EM | 1 |
| de Groot, M | 1 |
| Bosma, I | 1 |
| Sanchez, E | 1 |
| Douw, L | 1 |
| Heimans, JJ | 1 |
| Reijneveld, JC | 1 |
| Lagerwaard, FJ | 1 |
| Buter, J | 1 |
| Uitdehaag, BM | 1 |
| Klein, M | 1 |
| Postma, TJ | 1 |
| Durand, T | 1 |
| Jacob, S | 1 |
| Lebouil, L | 1 |
| Douzane, H | 1 |
| Lestaevel, P | 1 |
| Rahimian, A | 1 |
| Psimaras, D | 1 |
| Feuvret, L | 1 |
| Leclercq, D | 1 |
| Brochet, B | 1 |
| Tamarat, R | 1 |
| Milliat, F | 1 |
| Benderitter, M | 1 |
| Vayatis, N | 1 |
| Noël, G | 1 |
| Hoang-Xuan, K | 1 |
| Delattre, JY | 1 |
| Ricard, D | 1 |
| Bernier, MO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| EPIBRAINRAD : Study of Neurological Complication After Radiotherapy for Glioblastoma High Grade[NCT02544178] | 200 participants (Anticipated) | Observational | 2015-04-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for temozolomide and CACH Syndrome
| Article | Year |
|---|---|
LMNB1 mutation causes cerebellar involvement and a genome instability defect.
Topics: Adult; Cerebellum; Cisplatin; DNA Damage; Exome Sequencing; Female; Fibroblasts; Genomic Instability | 2017 |
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Atrophy; Brain Neoplasms; Cerebral Corte | 2014 |
EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Cognition Disorde | 2015 |